It has been eight years since weight-loss drug Ozempic hit the market, while Wegovy surfaced in 2021. Since then many reports have been written about the wider health benefits of the so-called wonder drugs.
Ozempic and Wegovy, which contain a medication called semaglutide, are manufactured by Novo Nordisk. Both drugs can be used by those with type 2 diabetes to help aid weight loss and manage blood sugar levels. However, Wegovy has since been approved in the UK to aid weight loss in those without diabetes. Since their launch, the pharma giant has seen a boom in profits, and it isn’t surprising to see why.
Research published this week claimed the drug could slow down ageing and has “far-reaching benefits” beyond what was originally imagined. The studies found those who took the drug died at a lower rate from all causes including cardiovascular diseases and Covid-19. The study covered 17,604 people who were overweight or obese and had an established cardiovascular disease.
Participants were given semaglutide or a placebo and were tracked for more than three years. Throughout the trial, a total of 833 participants died with 58 per cent of the deaths related to cardiovascular causes and 42 per cent to others.
Bu hikaye The Independent dergisinin September 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye The Independent dergisinin September 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Fernandes saves ponderous United with extra-time goal
A stray punch got the battle of Britain going, but it took the right boot of Bruno Fernandes to decide it.
Keys overcomes Swiatek power in semi-final thriller
Tennis has seen its fair share of mesmerising performances.
RFU chief executive vows to stay despite bonus row
A defiant Bill Sweeney has vowed to continue as chief executive of England's Rugby Football Union (RFU) until the 2027 Rugby World Cup, even as he faces a revolt within the game over his tenure.
Canelo vs Crawford is the super fight with a twist
Mexican idol and US star set for September meet as fight fixer Turki Alalshikh strikes again,
Consumer confidence in economy falls to new low’
Consumer expectations for the economy have plunged as the government faces continued pressure over public finances.
SLAVE TO THE BEAT
On 'Eusexua', her defiantly weird paean to the Prague rave scene, FKA twigs bends vital new electronic shapes, writes Helen Brown, while rapper Central Cee's debut delivers
Think kink: the distinctions between BDSM and abuse
Olivia Petter talks to sex educators about what differentiates a consensual sexual practice from abusive behaviour, and why it's so crucial for partners to understand these polarities
Air pollution crisis in focus ahead of Delhi's election
Toxic air in India’s capital, population more than 33 million, has become a key political issue,
Lost Tina Turner track casts light on her return to fame
A surprise treasure has been unearthed from Tina Turner's vaults: the previously unheard track \"Hot for You, Baby\", which was intended for use on her fifth solo album, Private Dancer.
Could Britain really join a European customs union?
Europe's new trade official responsible for post-Brexit negotiations has said a \"pan-European [customs] area\" is something the EU could consider as part of \"resetting\" relations between the UK post-Brexit and the EU.
